|
1
|
Smith RA, Manassaram-Baptiste D, Brooks D,
Doroshenk M, Fedewa S, Saslow D, Brawley OW and Wender R: Cancer
screening in the United States, 2015: A review of current American
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 65:30–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the Human
Development Index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Adams C, Grey N, Magrath I, Miller A and
Torode J: The World Cancer Declaration: Is the world catching up?
Lancet Oncol. 11:1018–1020. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bailly C: Ready for a comeback of natural
products in oncology. Biochem Pharmacol. 77:1447–1457. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Yang G, Li X, Zhang Y, Yang J, Chang
J, Sun X, Zhou X, Guo Y, Xu Y, et al: Traditional Chinese medicine
in cancer care: A review of controlled clinical studies published
in chinese. PLoS One. 8:e603382013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sen T and Samanta SK: Medicinal plants,
human health and biodiversity: A broad review. Adv Biochem Eng
Biotechnol. 147:59–110. 2015.PubMed/NCBI
|
|
7
|
Casey SC, Amedei A, Aquilano K, Azmi AS,
Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR,
et al: Cancer prevention and therapy through the modulation of the
tumor microenvironment. Semin Cancer Biol. Apr 10–2015.(Epub ahead
of print) doi: 10.1016/j.semcancer.2015.02.007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang
Z and Han J: The advantages of using traditional Chinese medicine
as an adjunctive therapy in the whole course of cancer treatment
instead of only terminal stage of cancer. Biosci Trends. 9:16–34.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jenkins VK, Timmons AK and McCall K:
Diversity of cell death pathways: Insight from the fly ovary.
Trends Cell Biol. 23:567–574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Romero A, Novoa B and Figueras A: The
complexity of apoptotic cell death in mollusks: An update. Fish
Shellfish Immunol. 46:79–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 12:770–776. 2000. View
Article : Google Scholar
|
|
15
|
Hensley P, Mishra M and Kyprianou N:
Targeting caspases in cancer therapeutics. Biol Chem. 394:831–843.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Poot SA, Lai KW, van der Wal L, Plasman
K, Van Damme P, Porter AC, Gevaert K and Bovenschen N: Granzyme M
targets topoisomerase II alpha to trigger cell cycle arrest and
caspase-dependent apoptosis. Cell Death Differ. 21:416–426. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chuang CH, Wang WJ, Li CF, Ko CY, Chou YH,
Chuu CP, Cheng TL and Wang JM: The combination of the prodrugs
perforin-CEBPD and perforin-granzyme B efficiently enhances the
activation of caspase signaling and kills prostate cancer. Cell
Death Dis. 5:e12202014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin J, Chen Y, Wei L, Chen X, Xu W, Hong
Z, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract
induces apoptosis via activation of the mitochondrion-dependent
pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338.
2010.PubMed/NCBI
|
|
19
|
Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang
B and Zheng S: Oxymatrine induces human pancreatic cancer PANC-1
cells apoptosis via regulating expression of Bcl-2 and IAP
families, and releasing of cytochrome c. J Exp Clin Cancer Res.
30:662011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo B, Zhang T, Su J, Wang K and Li X:
Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related
signaling pathways to suppress the proliferation and invasion of
gastric cancer cells. Cancer Chemother Pharmacol. 75:353–363. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu M, Zhao M, An C, Yang M, Li Q, Zhang Y,
Suetsugu A, Tome Y, Yano S, Fu Y, et al: Real-time imaging of
apoptosis induction of human breast cancer cells by the traditional
Chinese medicinal herb tubeimu. Anticancer Res. 32:2509–2514.
2012.PubMed/NCBI
|
|
22
|
Hsu SC and Chung JG: Anticancer potential
of emodin. BioMedicine. 2:108–116. 2012. View Article : Google Scholar
|
|
23
|
Zhang YK, Wang YJ, Gupta P and Chen ZS:
Multidrug resistance proteins (MRPs) and cancer therapy. AAPS J.
17:802–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilkens S: Structure and mechanism of ABC
transporters. F1000 Prime Rep. 7:142015. View Article : Google Scholar
|
|
25
|
Szakács G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leslie EM, Deeley RG and Cole SP:
Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2,
and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol.
204:216–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Fan L, Sun Y, Miao X, Zhang F, Meng
J, Han J, Zhang D, Zhang R, Yue Z, et al: Paris saponin VII from
Trillium tschonoskii reverses multidrug resistance of
adriamycin-resistant MCF-7/ADR cells via P-glycoprotein inhibition
and apoptosis augmentation. J Ethnopharmacol. 154:728–734. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cort A and Ozben T: Natural product
modulators to overcome multidrug resistance in cancer. Nutr Cancer.
67:411–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eichhorn T and Efferth T: P-glycoprotein
and its inhibition in tumors by phytochemicals derived from Chinese
herbs. J Ethnopharmacol. 141:557–570. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ugocsai K, Varga A, Molnár P, Antus S and
Molnár J: Effects of selected flavonoids and carotenoids on drug
accumulation and apoptosis induction in multidrug-resistant colon
cancer cells expressing MDR1/LRP. Vivo. 19:433–438. 2005.
|
|
31
|
Nabekura T, Kamiyama S and Kitagawa S:
Effects of dietary chemopreventive phytochemicals on P-glycoprotein
function. Biochem Biophys Res Commun. 327:866–870. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie XH, Zhao H, Hu YY and Gu XD:
Germacrone reverses Adriamycin resistance through cell apoptosis in
multidrug-resistant breast cancer cells. Exp Ther Med. 8:1611–1615.
2014.PubMed/NCBI
|
|
33
|
Hu T, To KK, Wang L, Zhang L, Lu L, Shen
J, Chan RL, Li M, Yeung JH and Cho CH: Reversal of P-glycoprotein
(P-gp) mediated multidrug resistance in colon cancer cells by
cryptotanshinone and dihydrotanshinone of Salvia
miltiorrhiza. Phytomedicine. 21:1264–1272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adams M, Mahringer A, Kunert O, Fricker G,
Efferth T and Bauer R: Cytotoxicity and p-glycoprotein modulating
effects of quinolones and indoloquinazolines from the Chinese herb
Evodia rutaecarpa. Planta Med. 73:1554–1557. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Adams M, Mahringer A, Bauer R, Fricker G
and Efferth T: In vitro cytotoxicity and P-glycoprotein modulating
effects of geranylated furocoumarins from Tetradium
daniellii. Planta Med. 73:1475–1478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu JY, Yu ZL, Fong WF and Shi YQ:
Chemotherapeutic activities of Carthami Flos and its
reversal effect on multidrug resistance in cancer cells. Afr J
Tradit Complement Altern Med. 10:36–40. 2013.PubMed/NCBI
|
|
37
|
Gordon MS, Mendelson DS and Kato G: Tumor
angiogenesis and novel antiangiogenic strategies. Int J Cancer.
126:1777–1787. 2010.PubMed/NCBI
|
|
38
|
Bikfalvi A, Moenner M, Javerzat S, North S
and Hagedorn M: Inhibition of angiogenesis and the
angiogenesis/invasion shift. Biochem Soc Trans. 39:1560–1564. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ziche M and Morbidelli L: Molecular
regulation of tumour angiogenesis by nitric oxide. Eur Cytokine
Netw. 20:164–170. 2009.PubMed/NCBI
|
|
40
|
Jinushi M: Immune regulation of
therapy-resistant niches: Emerging targets for improving anticancer
drug responses. Cancer Metastasis Rev. 33:737–745. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Z, Dabrosin C, Yin X, Fuster MM,
Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B,
Ribatti D, et al: Broad targeting of angiogenesis for cancer
prevention and therapy. Semin Cancer Biol. Jan 15–2015.(Epub ahead
of print) doi: 10.1016/j.semcancer.2015.01.001. View Article : Google Scholar
|
|
42
|
Cook KM and Figg WD: Angiogenesis
inhibitors: Current strategies and future prospects. CA Cancer J
Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lu KV, Chang JP, Parachoniak CA, Pandika
MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ,
Cheresh DA, et al: VEGF inhibits tumor cell invasion and
mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell.
22:21–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Eikesdal HP and Kalluri R: Drug resistance
associated with antiangiogenesis therapy. Semin Cancer Biol.
19:310–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wei L, Lin J, Xu W, Cai Q, Shen A, Hong Z
and Peng J: Scutellaria barbata D. Don inhibits tumor
angiogenesis via suppression of Hedgehog pathway in a mouse model
of colorectal cancer. Int J Mol Sci. 13:9419–9430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yan B, Liu L, Zhao Y, Xiu LJ, Sun DZ, Liu
X, Lu Y, Shi J, Zhang YC, Li YJ, et al: Xiaotan Sanjie decoction
attenuates tumor angiogenesis by manipulating Notch-1-regulated
proliferation of gastric cancer stem-like cells. World J
Gastroenterol. 20:13105–13118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang XF, Zhou QM, Du J, Zhang H, Lu YY and
Su SB: Baicalin suppresses migration, invasion and metastasis of
breast cancer via p38MAPK signaling pathway. Anticancer Agents Med
Chem. 13:923–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shen A, Lin J, Chen Y, Lin W, Liu L, Hong
Z, Sferra TJ and Peng J: Pien Tze Huang inhibits tumor angiogenesis
in a mouse model of colorectal cancer via suppression of multiple
cellular pathways. Oncol Rep. 30:1701–1706. 2013.PubMed/NCBI
|
|
49
|
Li F, Wang Y, Wang X, Li J, Cui H and Niu
M: Ganoderic acids suppress growth and angiogenesis by modulating
the NF-κB signaling pathway in breast cancer cells. Int J Clin
Pharmacol Ther. 50:712–721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wen-Sheng W: ERK signaling pathway is
involved in p15INK4b/p16INK4a expression and HepG2 growth
inhibition triggered by TPA and Saikosaponin a. Oncogene.
22:955–963. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lee Y-C, Cheng TH, Lee JS, Chen JH, Liao
YC, Fong Y, Wu CH and Shih YW: Nobiletin, a citrus flavonoid,
suppresses invasion and migration involving FAK/PI3K/Akt and small
GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell
Biochem. 347:103–115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang N and Feng Y, Cheung F, Wang X, Zhang
Z and Feng Y: A Chinese medicine formula Gegen Qinlian decoction
suppresses expansion of human renal carcinoma with inhibition of
matrix metalloproteinase-2. Integr Cancer Ther. 14:75–85. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Spurrell EL and Lockley M: Adaptive
immunity in cancer immunology and therapeutics.
Ecancermedicalscience. 8:4412014.PubMed/NCBI
|
|
54
|
Xiao W, Wu K, Yin M, Han S, Ding Y, Qiao
A, Lu G, Deng B, Bo P and Gong W: Wogonin inhibits tumor-derived
regulatory molecules by suppressing STAT3 signaling to promote
tumor immunity. J Immunother. 38:167–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fridman WH, Pagès F, Sautès-Fridman C and
Galon J: The immune contexture in human tumours: Impact on clinical
outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang CF, Lin SS, Liao PH, Young SC and
Yang C-C: The immunopharmaceutical effects and mechanisms of herb
medicine. Cell Mol Immunol. 5:23–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Peng Q, Cai H, Sun X, Li X, Mo Z and Shi
J: Alocasia cucullata exhibits strong antitumor effect in
vivo by activating antitumor immunity. PLoS One. 8:e753282013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ma YH, Cheng WZ, Gong F, Ma AL, Yu QW,
Zhang JY, Hu CY, Chen XH and Zhang DQ: Active Chinese mistletoe
lectin-55 enhances colon cancer surveillance through regulating
innate and adaptive immune responses. World J Gastroenterol.
14:5274–5281. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sun S, Zheng K, Zhao H, Lu C, Liu B, Yu C,
Zhang G, Bian Z, Lu A and He X: Regulatory effect of astragalus
polysaccharides on intestinal intraepithelial γδT cells of tumor
bearing mice. Molecules. 19:15224–15236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Su ZY and Sheen LY: An evidence-based
perspective of Ganoderma Lucidum (Lucid Ganoderma) for
cancer patients. Evidence-based Anticancer Materia Medica. Cho
W.C.S.: Springer. 245–263. 2011. View Article : Google Scholar
|
|
61
|
de la Taille A, Hayek OR, Burchardt M,
Burchardt T and Katz AE: Role of herbal compounds (PC-SPES) in
hormone-refractoryprostate cancer: Two case reports. J Altern
Complement Med. 6:449–451. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hsieh TC and Wu JM: Mechanism of action of
herbal supplement PC-SPES: Elucidation of effects of individual
herbs of PC-SPES on proliferation and prostate specific gene
expression in androgen-dependent LNCaP cells. Int J Oncol.
20:583–588. 2002.PubMed/NCBI
|
|
63
|
Gao Y, Zhou S, Jiang W, Huang M and Dai X:
Effects of ganopoly (a Ganoderma lucidum polysaccharide
extract) on the immune functions in advanced-stage cancer patients.
Immunol Invest. 32:201–215. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Donohoe CL, Ryan AM and Reynolds JV:
Cancer cachexia: Mechanisms and clinical implications.
Gastroenterol Res Pract. 2011:6014342011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zhang L, Wu C, Zhang Y, Liu F, Wang X,
Zhao M and Hoffman RM: Comparison of efficacy and toxicity of
traditional Chinese medicine (TCM) herbal mixture LQ and
conventional chemotherapy on lung cancer metastasis and survival in
mouse models. PLoS One. 9:e1098142014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhang L, Wu C, Zhang Y, Liu F, Zhao M,
Bouvet M and Hoffman RM: Efficacy comparison of traditional Chinese
medicine LQ versus gemcitabine in a mouse model of pancreatic
cancer. J Cell Biochem. 114:2131–2137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo
N, Li XK and Tang W: Chinese herbal medicines as adjuvant treatment
during chemo- or radio-therapy for cancer. Biosci Trends.
4:297–307. 2010.PubMed/NCBI
|
|
68
|
Zhou QM, Wang XF, Liu XJ, Zhang H, Lu YY,
Huang S and Su SB: Curcumin improves MMC-based chemotherapy by
simultaneously sensitising cancer cells to MMC and reducing
MMC-associated side-effects. Eur J Cancer. 47:2240–2247. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Shakibaei M, Kraehe P, Popper B, Shayan P,
Goel A and Buhrmann C: Curcumin potentiates antitumor activity of
5-fluorouracil in a 3D alginate tumor microenvironment of
colorectal cancer. BMC Cancer. 15:2502015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang H, Chan YL, Li TL and Wu CJ:
Improving cachectic symptoms and immune strength of tumour-bearing
mice in chemotherapy by a combination of Scutellaria
baicalensis and Qing-Shu-Yi-Qi-Tang. Eur J Cancer.
48:1074–1084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li SG, Chen HY, Ou-Yang CS, Wang X-X, Yang
Z-J, Tong Y and Cho WC: The efficacy of Chinese herbal medicine as
an adjunctive therapy for advanced non-small cell lung cancer: A
systematic review and meta-analysis. PLoS One. 8:e576042013.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Singh SR, Tan M and Rameshwar P: Cancer
metabolism: Targeting metabolic pathways in cancer therapy. Cancer
Lett. 356(2 Pt A): 147–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Nowarski R, Gagliani N, Huber S and
Flavell RA: Innate immune cells in inflammation and cancer. Cancer
Immunol Res. 1:77–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Nobili S, Lippi D, Witort E, Donnini M,
Bausi L, Mini E and Capaccioli S: Natural compounds for cancer
treatment and prevention. Pharmacol Res. 59:365–378. 2009.
View Article : Google Scholar : PubMed/NCBI
|
